Rapamycin inhibits didemnin B-induced apoptosis in human HL-60 cells: Evidence for the possible involvement of FK506-binding protein 25

Immunology and Cell Biology

Volumn 77, Issue 3, 1999, Pages 242-248

  Johnson, Karina L ^a   Lawen, Alfons ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Apoptosis; Didemnin B; Rapamycin

Indexed keywords

CYCLIN DEPENDENT KINASE; DIDEMNIN B; FK 506 BINDING PROTEIN; RAPAMYCIN;

APOPTOSIS; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; PROTEIN LOCALIZATION;

ANDROSTADIENES; APOPTOSIS; CYCLIN-DEPENDENT KINASES; DEPSIPEPTIDES; HL-60 CELLS; HUMANS; IMMUNOPHILINS; IMMUNOSUPPRESSIVE AGENTS; PEPTIDES, CYCLIC; SIROLIMUS; TACROLIMUS; TACROLIMUS BINDING PROTEINS; TIME FACTORS;

EID: 0033011588     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00821.x     Document Type: Conference Paper

References (35)

1. 1 Rinehart Jr KL, Gloer JB, Hughes Jr RG et al. Didemnins: Antiviral and antitumour depsipeptides from a caribbean tunicate. Science 1981; 212: 933-5.
2. 2 Montgomery DM, Zukoski CF. Didemnin B: A new immunosuppressive cyclic peptide with potent activity in vitro and in vivo. Transplantation 1985; 40: 49-56.
3. 3 Grubb DR, Wolvetang EJ, Lawen A. Didemnin B induces cell death by apoptosis. The fastest induction of apoptosis ever described. Biochem. Biophys. Res. Commun. 1995; 215: 1130-6.
4. 4 Johnson KL, Vaillant F, Lawen A. Protein tyrosine kinase inhibitors prevent didemnin B-induced apoptosis in III.-60 cells. FEBS Lett. 1996; 383: 1-5.
5. 5 Johnson KL, Grubb DR, Lawen A. Unspecific activation of caspases during the induction of apoptosis by didemnin B in human cell lines. J. Cell. Biochem. 1999; 72: 269-78.
6. 6 Dumont FJ, Su Q. Mechanism of action of the immunosuppressant rapamycin. Life Sci. 1996; 58: 373-95.
7. 7 Schreiber SL. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 1991; 251: 283-7.
8. 8 Lawen A. Biosynthesis and mechanism of action of cyclosporins. Prog. Med. Chem. 1996; 33: 53-97.
9. 9 Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH. RAFTI: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 1994; 78: 35-43.
10. 10 Brown EJ, Albers MW, Shin TB et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994; 369: 756-8.
11. 11 Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 1992; 69: 1227-36.
12. 12 Brown EJ, Beal PA, Keith CT, Chen J, Shin TB, Schreiber SL. Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature 1995; 377: 441-5.
13. 13 Russell WC, Newman C, Williamson DH. A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature 1975; 253: 461-2.
14. 14 Johnson GD, Araujo GM. A simple method of reducing the fading of immunofluorescence during microscopy. J. Immunol. Methods 1981; 43: 349-50.
15. 15 Wigler MH, Weinstein IB. A preparative method for obtaining enucleated mammalian cells. Biochem. Biophys. Res. Commun. 1975; 63: 669-74.
16. 16 Wolvetang EJ, Larm JA, Moutsoulas P, Lawen A. Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ. 1996; 7: 1315-25.
17. 17 Yano H, Nakanishi S, Kimura K et al. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 1993; 268: 25 846-56.
18. 18 Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 1995; 270: 27 489-94.
19. 19 Albers MW, Williams RT, Brown EJ, Tanaka A, Hall FL, Schreiber SL. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. J. Biol. Chem. 1993; 268: 22 825-9.
20. cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes. J. Biol. Chem. 1993; 268: 3734-8.
21. 21 Abraham RT, Acquarone M, Andersen A et al. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biol. Cell 1995; 83: 105-20.
22. 22 Meijer L, Borgne A, Mulner O et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 1997; 243: 527-36.
23. 23 Galat A, Lane WS, Standaert RF, Schreiber SL. A rapamycin-selective 25-kDa immunophilin. Biochemistry 1992; 31: 2427-34.
24. 24 Jin YJ, Burakoff SJ. The 25-kDa FK506-binding protein is localized in the nucleus and associates with casein kinase II and nucleolin. Proc. Natl Acad. Sci. USA 1993; 90: 7769-73.
25. 25 Rivière S, Ménez A, Galat A. On the localization of FKBP25 in T-lymphocytes. FEBS Lett. 1993; 315: 247-51.
26. S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 1994; 370: 71-5.
27. 27 Weng QP, Andrabi K, Klippel A, Kozlowski MT, Williams LT, Avruch J. Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proc. Natl Acad. Sci. USA 1995; 92: 5744-8.
28. s6k phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol. Cell. Biol. 1996; 16: 6242-51.
29. 29 Lenormand P, McMahon M, Pouysségur J. Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway. J. Biol. Chem. 1996; 271: 15 762-8.
30. 30 Rousse S, Montarras D, Pinset C, Dubois C. Up-regulation of insulin-like growth factor binding protein-5 is independent of muscle cell differentiation, sensitive to rapamycin, but insensitive to wortmannin and LY294002. Endocrinology 1998; 139: 1487-93.
31. 31 Bierer BE, Mattila PS, Standaert RF et al. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc. Natl Acad. Sci. USA 1990; 87: 9231-5.
32. 32 Nielsen JB, Poor F, Sickierka JJ et al. Yeast FKBP-13 is a membrane-associated FK506-binding protein encoded by the non-essential gene FKB2. Proc. Natl Acad. Sci. USA 1992; 89: 7471-5.
33. 33 Baughman G, Wiederrecht GJ, Campbell NF, Martin MM, Bourgeois S. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol. Cell. Biol. 1995; 15: 4395-402.
34. 34 Coss MC, Winterstein D, Sowder II RC, Simek SL. Molecular cloning, DNA sequence analysis, and biochemical characterization of a novel 65-kDa FK506-binding protein (FKBP65). J. Biol. Chem. 1995; 270: 29 336-41.
35. 35 Schulze-Osthoff K, Walczak H, Dröge W, Krammer PK. Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell Biol. 1994; 127: 15-20.